Cargando…

Gray matter changes in asymptomatic C9orf72 and GRN mutation carriers

Frontotemporal dementia (FTD) is a neurodegenerative disease with a strong genetic basis. Understanding the structural brain changes during pre-symptomatic stages may allow for earlier diagnosis of patients suffering from FTD; therefore, we investigated asymptomatic members of FTD families with muta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Popuri, Karteek, Dowds, Emma, Beg, Mirza Faisal, Balachandar, Rakesh, Bhalla, Mahadev, Jacova, Claudia, Buller, Adrienne, Slack, Penny, Sengdy, Pheth, Rademakers, Rosa, Wittenberg, Dana, Feldman, Howard H., Mackenzie, Ian R., Hsiung, Ging-Yuek R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964622/ https://www.ncbi.nlm.nih.gov/pubmed/29845007 http://dx.doi.org/10.1016/j.nicl.2018.02.017

Ejemplares similares

White-matter abnormalities in presymptomatic GRN and C9orf72 mutation carriers
por: Lee, Hyunwoo, et al.
Publicado: (2022)

FDG-PET in presymptomatic C9orf72 mutation carriers
por: Popuri, Karteek, et al.
Publicado: (2021)

Development and validation of a novel dementia of Alzheimer's type (DAT) score based on metabolism FDG-PET imaging
por: Popuri, Karteek, et al.
Publicado: (2018)

Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants
por: Staffaroni, Adam M., et al.
Publicado: (2020)

White matter lesions in FTLD: distinct phenotypes characterize GRN and C9ORF72 mutations
por: Ameur, Fatima, et al.
Publicado: (2016)

C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers
por: Rizzu, Patrizia, et al.
Publicado: (2016)

Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET images
por: Lu, Donghuan, et al.
Publicado: (2018)

Plasma Small Extracellular Vesicles with Complement Alterations in GRN/C9orf72 and Sporadic Frontotemporal Lobar Degeneration
por: Bellini, Sonia, et al.
Publicado: (2022)

Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations
por: Marian, Oana C., et al.
Publicado: (2023)

Plasma Small Extracellular Vesicle Cathepsin D Dysregulation in GRN/C9orf72 and Sporadic Frontotemporal Lobar Degeneration
por: Bellini, Sonia, et al.
Publicado: (2022)

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort
por: Van Mossevelde, Sara, et al.
Publicado: (2016)

Profiling of Ubiquitination Pathway Genes in Peripheral Cells from Patients with Frontotemporal Dementia due to C9ORF72 and GRN Mutations
por: Serpente, Maria, et al.
Publicado: (2015)

Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients
por: Guven, Gamze, et al.
Publicado: (2016)

Quantifying brain metabolism from FDG‐PET images into a probability of Alzheimer's dementia score
por: Yee, Evangeline, et al.
Publicado: (2019)

Plasma NfL levels and longitudinal change rates in C9orf72 and GRN-associated diseases: from tailored references to clinical applications
por: Saracino, Dario, et al.
Publicado: (2021)

The PINK1 p.Asn521Thr Variant Is Associated with Earlier Disease Onset in GRN/C9orf72 Frontotemporal Lobar Degeneration
por: Rossi, Giacomina, et al.
Publicado: (2022)

Distinguishing post‐translational modifications in dominantly inherited frontotemporal dementias: FTLD‐TDP Type A (GRN) vs Type B (C9orf72)
por: Cracco, Laura, et al.
Publicado: (2022)

Using machine learning to quantify structural MRI neurodegeneration patterns of Alzheimer's disease into dementia score: Independent validation on 8,834 images from ADNI, AIBL, OASIS, and MIRIAD databases
por: Popuri, Karteek, et al.
Publicado: (2020)

Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene
por: van Blitterswijk, Marka, et al.
Publicado: (2014)

Unaffected mosaic C9orf72 case: RNA foci, dipeptide proteins, but upregulated C9orf72 expression
por: McGoldrick, Philip, et al.
Publicado: (2018)

Differential Diagnosis of Frontotemporal Dementia, Alzheimer's Disease, and Normal Aging Using a Multi-Scale Multi-Type Feature Generative Adversarial Deep Neural Network on Structural Magnetic Resonance Images
por: Ma, Da, et al.
Publicado: (2020)

Agreement between Patient and Proxy Assessments of Quality of Life among Older Adults with Vascular Cognitive Impairment Using the EQ-5D-3L and ICECAP-O
por: Davis, Jennifer C., et al.
Publicado: (2016)

Gyrification abnormalities in presymptomatic c9orf72 expansion carriers
por: Caverzasi, Eduardo, et al.
Publicado: (2019)

Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
por: Sattler, Rita, et al.
Publicado: (2023)

Promotion of the mind through exercise (PROMoTE): a proof-of-concept randomized controlled trial of aerobic exercise training in older adults with vascular cognitive impairment
por: Liu-Ambrose, Teresa, et al.
Publicado: (2010)

Microglia in frontotemporal lobar degeneration with progranulin or C9ORF72 mutations
por: Sakae, Nobutaka, et al.
Publicado: (2019)

Morphological alterations in the caudate, putamen, pallidum, and thalamus in Parkinson's disease
por: Garg, Amanmeet, et al.
Publicado: (2015)

Associations between cerebral amyloid and changes in cognitive function and falls risk in subcortical ischemic vascular cognitive impairment
por: Dao, Elizabeth, et al.
Publicado: (2017)

Clinical and neuropathological features of ALS/FTD with TIA1 mutations
por: Hirsch-Reinshagen, Veronica, et al.
Publicado: (2017)

Treatment implications of C9ORF72
por: Sha, Sharon J, et al.
Publicado: (2012)

Case report: TMEM106B haplotype alters penetrance of GRN mutation in frontotemporal dementia family
por: Perneel, Jolien, et al.
Publicado: (2023)

Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers
por: Lee, Suzee E., et al.
Publicado: (2016)

Novel GRN mutation presenting as an aphasic dementia and evolving into corticobasal syndrome
por: Botha, Hugo, et al.
Publicado: (2017)

Exploring the effects of coexisting amyloid in subcortical vascular cognitive impairment
por: Dao, Elizabeth, et al.
Publicado: (2015)

Erratum to: Exploring the effects of coexisting amyloid in subcortical vascular cognitive impairment
por: Dao, Elizabeth, et al.
Publicado: (2016)

Neuroimaging features of C9ORF72 expansion
por: Yokoyama, Jennifer S, et al.
Publicado: (2012)

C9orf72 immunohistochemistry in Alzheimer's disease
por: Hortobágyi, Tibor
Publicado: (2012)

The Enigmatic Role of C9ORF72 in Autophagy
por: Nassif, Melissa, et al.
Publicado: (2017)

Network‐wise concordance of multimodal neuroimaging features across the Alzheimer's disease continuum
por: Stocks, Jane, et al.
Publicado: (2022)

Neuronal Transcriptome from C9orf72 Repeat Expanded Human Tissue is Associated with Loss of C9orf72 Function
por: Liu, Elaine Y., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g919jloohfqqd89bsauvi66pnj